Relationship between Body Mass Index and Overactive Bladder in Women and Correlations with Urodynamic Evaluation
- PMID: 23094218
- PMCID: PMC3469831
- DOI: 10.5213/inj.2012.16.3.126
Relationship between Body Mass Index and Overactive Bladder in Women and Correlations with Urodynamic Evaluation
Abstract
Purpose: Overactive bladder (OAB) is a common condition. In women, studies have shown that the prevalence of OAB is positively related to increasing body mass index (BMI). Our objective was to define a relationship between BMI and OAB through correlation with urodynamic study (UDS).
Methods: A prospective study was conducted. Ambulatory women aged 18 years or older who had symptoms of OAB for at least 3 months were enrolled. Patients answered a questionnaire, had their weight and height recorded, and underwent UDS. Patients were categorized into 3 groups as follows: group 1, BMI<25; group 2, BMI 25 to 29.9; and group 3, BMI≥30.
Results: A total of 113 patients were examined (group 1, n=32; group 2, n=40; group 3, n=41). The patients' mean ages were 50, 55, and 59 years for groups 1, 2, and 3, respectively (P<0.05). Group 3 showed a significant increase in the incidence of subjective mixed leakage and the number of pads used compared with groups 1 and 2. No significant differences were seen among the groups in duration of symptoms, OAB V-8 score, or the incidence of subjective urgency or stress leakage. The UDS parameters of groups 1, 2, and 3 showed no statistically significant differences for most variables. Group 3 showed a significant increase in the incidence of urge leakage by UDS compared with group 2 only.
Conclusions: Increasing BMI was age related. A BMI≥30 showed a higher incidence of subjective urinary mixed leakage and pad use. UDS showed no significant correlation between OAB and any BMI category for most UDS parameters.
Keywords: Body mass index; Overactive urinary bladder; Risk factors; Urodynamics.
Conflict of interest statement
Sidney B. Radomski is advisory board member of Astellas, Pfizer, Allergan and researcher for Astellas and Allergan.
Similar articles
-
Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?BJU Int. 2013 Aug;112(4):501-7. doi: 10.1111/j.1464-410X.2012.11652.x. Epub 2013 Mar 4. BJU Int. 2013. PMID: 23452071
-
Correlation between overactive bladder and detrusor overactivity: a retrospective study.Int Urogynecol J. 2023 Apr;34(4):867-875. doi: 10.1007/s00192-022-05274-7. Epub 2022 Jun 25. Int Urogynecol J. 2023. PMID: 35751673
-
Is urodynamic evaluation able to change and improve the management of women with idiopathic overactive bladder?Minerva Urol Nephrol. 2021 Dec;73(6):823-830. doi: 10.23736/S2724-6051.20.03801-1. Epub 2020 Jun 22. Minerva Urol Nephrol. 2021. PMID: 32573171
-
Impact of urodynamic evaluation on the treatment of women with idiopathic overactive bladder: a systematic review.Minerva Urol Nefrol. 2020 Aug;72(4):420-426. doi: 10.23736/S0393-2249.20.03685-1. Epub 2020 Jan 30. Minerva Urol Nefrol. 2020. PMID: 32026667
-
Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management.Neurourol Urodyn. 2018 Jan;37(1):83-88. doi: 10.1002/nau.23328. Epub 2017 Jun 20. Neurourol Urodyn. 2018. PMID: 28631830 Review.
Cited by
-
Lower Urinary Tract Symptoms Among Females with Rheumatoid Arthritis: A Prospective Cross-Sectional Study.Int J Gen Med. 2021 Nov 18;14:8427-8435. doi: 10.2147/IJGM.S333423. eCollection 2021. Int J Gen Med. 2021. PMID: 34819750 Free PMC article.
-
Association between overactive bladder and pelvic organ mobility as evaluated by dynamic magnetic resonance imaging.Sci Rep. 2021 Jul 2;11(1):13726. doi: 10.1038/s41598-021-93143-6. Sci Rep. 2021. PMID: 34215810 Free PMC article.
-
The Urobiome and Its Role in Overactive Bladder.Int Neurourol J. 2022 Sep;26(3):190-200. doi: 10.5213/inj.2244016.008. Epub 2022 Apr 22. Int Neurourol J. 2022. PMID: 35468617 Free PMC article.
-
Association between weight-adjusted waist index and overactive bladder: a cross-sectional study based on 2009-2018 NHANES.Front Nutr. 2024 Sep 4;11:1423148. doi: 10.3389/fnut.2024.1423148. eCollection 2024. Front Nutr. 2024. PMID: 39296511 Free PMC article.
-
Impact of body mass index on the efficacy of treatment modalities in women with refractory overactive bladder.Sci Rep. 2024 Dec 2;14(1):29990. doi: 10.1038/s41598-024-81795-z. Sci Rep. 2024. PMID: 39623125 Free PMC article.
References
-
- Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6(11 Suppl):S580–S590. - PubMed
-
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–178. - PubMed
-
- Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology. 2002;60(5 Suppl 1):7–12. - PubMed
-
- Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–336. - PubMed
-
- Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760–766. - PubMed
LinkOut - more resources
Full Text Sources